跳至主要内容
临床试验/NCT03041493
NCT03041493终止不适用

Investigation of the Effects of Electronic Cigarettes on Vascular Health

Memorial Sloan Kettering Cancer Center2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2017年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
12
试验地点
2
主要终点
Differences in levels of F2-isoprostanes in participants

研究概览

简要总结

The goal is find out if the use of Electronic cigarettes (EC) leads to the same changes that we see in blood vessels of traditional cigarettes (TC) users. The investigators will also enroll non-smokers as "controls", against which they will measure changes in blood vessels in TC and EC users.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female between 18 and 50 years of age.
  • Good general health with no history of diabetes, coronary artery disease, peripheral arterial disease, chronic disease or hypertension.
  • Ability to sign an informed consent.
  • Tobacco product users will have additional inclusion criteria:
  • For TC smokers, daily TC smoking in the past 6 months, at least 10 cigarettes per day, with no EC exposure in the past 6 months
  • For EC users, daily EC use in the past 6 months, at least 10 sessions per day, with no TC exposure in the past 6 month
  • For non-smokers, no significant lifetime exposure to any nicotine-containing product, where significant exposure is defined as daily use of any nicotine-containing product for more than one week or once monthly use for more than 6 months.

排除标准

  • History of renal disease, hypertension, diabetes, congestive heart failure or emphysema
  • Use of ACE inhibitors, Angiotensin II receptor blockers, diuretics, aldosterone, renin blockers, aspirin, statins, sildenafil (or other PDE5 inhibitors) and NSAIDs.
  • History of substance abuse
  • Currently using nicotine replacement or other tobacco cessation products or intentionally abstaining from nicotine-containing products
  • IV contrast exposure in the past 1 month
  • Inability to place an IV catheter or draw blood for any reason
  • Pregnant women or breastfeeding
  • Potential subjects will be asked if they are pregnant. Verbal confirmation of pregnancy will be sufficient.
  • Fever of >101°F or BP >180/95

结局指标

主要结局

Differences in levels of F2-isoprostanes in participants

时间窗: 2 years

F2-isoprostanes in blood and urine

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Investigation of the Effects of Electronic... | 临床试验